MTOR and neoplasm: Given the early and sustained induction of pS6 in GLI2A-expressing gastric cancers, we tested the function of mTOR signaling in tumorigenesis by treating mice with the mTOR inhibitor rapamycin, which resulted in a strong inhibition of tumor growth in iLgr5;GLI2A mice (Figure 6A).